On December 7th, 6 people including Ms. Xiulan Wu, Manager of Supply Chain and Quality Management of Boston Scientific, Ms. Ningjun Chen, Senior Tax and Accounting Manager, visited Lingang Innovation Center Overseas Affairs Department. Mr. Hongfei Zhang, General Manager of Lingang Innovation Center Overseas Affairs Department, and Mr.Hua Yang, President of the Global Cross-Border Technology Exchange, received the guests.
Mr. Hongfei Zhang introduced the Lingang Innovation Center and the policies of the Lingang area to the guests in detail. Lingang Innovation Center was established in 2009 by the Shanghai Municipal Science and Technology Commission. It is a national technology business incubator featuring intelligent manufacturing. It relies on Shanghai Technology Exchange, National Technology Transfer Eastern Center, Yangpu Venture Incubation Group, and the Global Cross-Border Technology Exchange. The high-quality resources of the trade center and offshore industry incubation base are committed to industry incubation and fostering innovation clusters of technology enterprises. As a hot spot for the country’s reform and opening up, the Lingang Special Area has formulated a series of industrial, taxation, and talent policies that are conducive to the development of high-tech enterprises in accordance with the highest standards and the highest standards. Boston Scientific fits well in the four major sectors of Lingang It is believed that the biomedical sector in Lingang can achieve good development.
Ms. Ningjun Chen introduced the specific situation of Boston Scientific. Founded in 1979 and headquartered in Natick, Massachusetts, Boston Scientific is the world’s leading medical technology company. In 1997, Boston Scientific entered China and established branches and R&D centers in Beijing, Shanghai, and Guangzhou. The core business areas in China are cardiac intervention, cardiac rhythm management and electrophysiology, structural heart disease, endoscopic intervention, respiratory, peripheral and tumor intervention, and urinary and women’s health. After entering the Chinese market for more than 20 years, the company has achieved good results and hopes to seek further development. Lingang is located in Shanghai and is at the forefront of domestic reform and opening up, which is very attractive to Boston Scientific.
The two parties conducted in-depth exchanges on policy details and company needs and other details, and expressed that they will continue to maintain contact, through continuous communication to clarify the possible and direction of cooperation, and hope to settle in Lingang Innovation Center as soon as possible.